Effects of the calcium channel blocker nifedipine on epiphyseal growth plate and bone turnover: A study in rabbit
- 1 February 1993
- journal article
- research article
- Published by Springer Science and Business Media LLC in Calcified Tissue International
- Vol. 52 (2), 120-124
- https://doi.org/10.1007/bf00308320
Abstract
The potential effects of a calcium channel blocker (nifedipine) on epiphyseal growth plate and bone remodeling have been investigated in growing rabbits. The treated group received 6 mg/kg/day nifedipine twice daily by gavage for 10 weeks. An untreated group was used as control; with this dose, neither toxic effects nor decrease in the body weight have been observed. No modifications of blood phosphocalcic parameters have been found. In the treated group there is a significant lower cancellous bone volume, lower osteogenesis, shorter labeled perimeters, and lower mineral apposition rate than in the control group. Epiphyseal growth plate thickness is lower than in the untreated animals and considerable morphological changes are observed in the growth zone compared with the control group. A decrease in the growth of humerus length was found. In conclusion, nifedipine affects bone physiology, especially with consequences on bone growth. These effects appear to be quantitatively important, and there is the possibility of bone side effects on therapeutic use in humans, especially in young subjects.Keywords
This publication has 25 references indexed in Scilit:
- Chronic use of the calcium channel blocker nifedipine has no significant effect on bone metabolism in menBone, 1991
- Verapamil increases serum alkaline phosphatase in hypertensive patientsJournal of Internal Medicine, 1990
- Analogous Effects of Organic Calcium Antagonists and Magnesium on the Epiphyseal Growth PlatePublished by Ovid Technologies (Wolters Kluwer Health) ,1990
- The effect of diltiazem on calcinosis in a patient with the crest syndromeArthritis & Rheumatism, 1990
- Intracellular calcium in the control of osteoclast function. II. Paradoxical elevation of cytosolic free calcium by verapamilBiochemical and Biophysical Research Communications, 1990
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987
- Calcium metabolism in uremic nephrocalcinosis: Preventive effect of verapamilKidney International, 1985
- Effects of the Calcium Antagonist, Diltiazem onIn VitroandIn Vivo/In VitroBone ResorptionHormone and Metabolic Research, 1985
- Histomorphometric analysis of dynamic parameters of trabecular bone formation in the iliac crest of Normal British subjectsMetabolic Bone Disease and Related Research, 1984
- Inhibition of 1α‐hydroxy‐vitamin D3 stimulated bone resorption in tissue culture by the calcium antagonist verapamilEuropean Journal of Clinical Investigation, 1982